APP and Alzheimer disease: Finally, TUDCA supplementation prevents cognitive impairment in APP/PS1 transgenic AD mice, which display intact spatial recognition and contextual memory, together with a general reduction in amyloid deposition in the hippocampus and prefrontal cortex [52].